Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu randomizované kontrolované studie, multicentrická studie, časopisecké články, práce podpořená grantem
PubMed
38315126
PubMed Central
PMC10843418
DOI
10.1097/hc9.0000000000000376
PII: 02009842-202402010-00016
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- mozková smrt MeSH
- následné studie MeSH
- perfuze metody MeSH
- přežívání štěpu MeSH
- transplantace jater * škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: While 4 randomized controlled clinical trials confirmed the early benefits of hypothermic oxygenated machine perfusion (HOPE), high-level evidence regarding long-term clinical outcomes is lacking. The aim of this follow-up study from the HOPE-ECD-DBD trial was to compare long-term outcomes in patients who underwent liver transplantation using extended criteria donor allografts from donation after brain death (ECD-DBD), randomized to either HOPE or static cold storage (SCS). METHODS: Between September 2017 and September 2020, recipients of liver transplantation from 4 European centers receiving extended criteria donor-donation after brain death allografts were randomly assigned to HOPE or SCS (1:1). Follow-up data were available for all patients. Analyzed endpoints included the incidence of late-onset complications (occurring later than 6 months and graded according to the Clavien-Dindo Classification and the Comprehensive Complication Index) and long-term graft survival and patient survival. RESULTS: A total of 46 patients were randomized, 23 in both arms. The median follow-up was 48 months (95% CI: 41-55). After excluding early perioperative morbidity, a significant reduction in late-onset morbidity was observed in the HOPE group (median reduction of 23 Comprehensive Complication Index-points [p=0.003] and lower incidence of major complications [Clavien-Dindo ≥3, 43% vs. 85%, p=0.009]). Primary graft loss occurred in 13 patients (HOPE n=3 vs. SCS n=10), resulting in a significantly lower overall graft survival (p=0.029) and adverse 1-, 3-, and 5-year survival probabilities in the SCS group, which did not reach the level of significance (HOPE 0.913, 0.869, 0.869 vs. SCS 0.783, 0.606, 0.519, respectively). CONCLUSIONS: Our exploratory findings indicate that HOPE reduces late-onset morbidity and improves long-term graft survival providing clinical evidence to further support the broad implementation of HOPE in human liver transplantation.
Department of General Surgery and Liver Transplantation Fundeni Clinical Institute Bucharest Romania
Department of Internal Medicine 3 University Hospital RWTH Aachen Aachen Germany
Department of Surgery and Transplantation University Hospital RWTH Aachen Aachen Germany
Zobrazit více v PubMed
Schlegel A, Muller X, Kalisvaart M, Muellhaupt B, Perera MTPR, Isaac JR, et al. . Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation. J Hepatol. 2019;70:50–7. PubMed
Czigany Z, Lurje I, Tolba RH, Neumann UP, Tacke F, Lurje G. Machine perfusion for liver transplantation in the era of marginal organs—New kids on the block. Liver Int. 2019;39:228–49. PubMed
Blok JJ, Braat AE, Adam R, Burroughs AK, Putter H, Kooreman NG, et al. . Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver transplant. 2012;18:112–9. PubMed
Moosburner S, Sauer IM, Förster F, Winklmann T, Gassner JMGV, Ritschl PV, et al. . Early allograft dysfunction increases hospital associated costs after liver transplantation—A propensity score-matched analysis. Hepatol Commun. 2021;5:526–37. PubMed PMC
Czigany Z, Lurje I, Schmelzle M, Schöning W, Öllinger R, Raschzok N, et al. . Ischemia-reperfusion injury in marginal liver grafts and the role of hypothermic machine perfusion: molecular mechanisms and clinical implications. J Clin Med. 2020;9:846. PubMed PMC
Pavicevic S, Uluk D, Reichelt S, Fikatas P, Globke B, Raschzok N, et al. . Hypothermic oxygenated machine perfusion for extended criteria donor allografts—Preliminary experience with extended organ preservation times in the setting of organ reallocation. Artif Organs. 2021. doi:10.1111/aor.14103 PubMed DOI
Brüggenwirth IMA, Mueller M, Lantinga VA, Camagni S, De Carlis R, De Carlis L, et al. . Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: A European observational cohort study. Am J Transplant. 2022;22:1842–51. PubMed PMC
Schlegel A, Mueller M, Muller X, Eden J, Panconesi R, von Felten S, et al. . A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. J Hepatol. 2023;78:783–93. PubMed
van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, et al. . Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial. N Engl J Med. 2021;384:1391–401. PubMed
Ravaioli M, Germinario G, Dajti G, Sessa M, Vasuri F, Siniscalchi A, et al. . Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial. Am J Transplant. 2022;22:2401–8. PubMed PMC
Sousa Da Silva RX, Weber A, Dutkowski P, Clavien PA. Machine perfusion in liver transplantation. Hepatology (Baltimore, Md). 2022;76:1531–49. PubMed
Czigany Z, Schöning W, Ulmer TF, Bednarsch J, Amygdalos I, Cramer T, et al. . Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): A prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open. 2017;7:e017558. PubMed PMC
Czigany Z, Pratschke J, Froněk J, Guba M, Schöning W, Raptis DA, et al. . Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: Results from a multicenter randomized controlled trial (HOPE ECD-DBD). Ann Surg. 2021;274:705–12. PubMed
Grąt M, Morawski M, Zhylko A, Rykowski P, Krasnodebski M, Wyporski A, et al. . Routine end-ischemic hypothermic oxygenated machine perfusion in liver transplantation from donors after brain death: A randomized controlled trial. Ann Surg. 2023;278:662–8. PubMed
Zimmermann J, Carter AW. Cost-utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation. Br J Surg. 2022;109:e31–2. PubMed PMC
Czigany Z, Tacke F, Lurje G. Evolving trends in machine liver perfusion: Comments on clinical end points and selection criteria. Gastroenterology. 2019;157:1166–7. PubMed
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C . Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med. 2008;148:295–309. PubMed
van den Brand JA, van Boekel GA, Willems HL, Kiemeney LA, den Heijer M, Wetzels JF. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant. 2011;26:3176–81. PubMed
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. . The Clavien-Dindo classification of surgical complications: Five-year experience. Ann Surg. 2009;250:187–96. PubMed
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: A novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1–7. PubMed
Rayar M, Beaurepaire JM, Bajeux E, Hamonic S, Renard T, Locher C, et al. . Hypothermic oxygenated perfusion improves extended criteria donor liver graft function and reduces duration of hospitalization without extra cost: The PERPHO Study. Liver transplant. 2021;27:349–62. PubMed
Ramírez-Del Val A, Guarrera J, Porte RJ, Selzner M, Spiro M, Raptis DA, et al. . Does machine perfusion improve immediate and short-term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta-analysis and expert panel recommendations. Clin Transplant. 2022;36:e14638. PubMed
Patrono D, Cussa D, Sciannameo V, Montanari E, Panconesi R, Berchialla P, et al. . Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors. Am J Transplant. 2022;22:1382–95. PubMed PMC
Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, et al. . Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant. 2010;10:372–81. PubMed
Guarrera JV, Henry SD, Samstein B, Reznik E, Musat C, Lukose TI, et al. . Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant. 2015;15:161–9. PubMed
Dutkowski P, Polak WG, Muiesan P, Schlegel A, Verhoeven CJ, Scalera I, et al. . First comparison of hypothermic oxygenated PErfusion versus static cold storage of human donation after cardiac death liver transplants: An International-matched Case Analysis. Ann Surg. 2015;262:764–70; discussion 770-761. PubMed
Dutkowski P, Schlegel A, de Oliveira M, Müllhaupt B, Neff F, Clavien PA. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014;60:765–72. PubMed
van Rijn R, Karimian N, Matton APM, Burlage LC, Westerkamp AC, van den Berg AP, et al. . Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. Br J Surg. 2017;104:907–17. PubMed PMC
van Rijn R, van den Berg AP, Erdmann JI, Heaton N, van Hoek B, de Jonge J, et al. . Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterol. 2019;19:40. PubMed PMC